McKesson Corporation (MCK) Market Cap & Valuation Ratios
McKesson Corporation (MCK) has a market cap of $116.7B, a trailing P/E of 26.8 and a price-to-sales ratio of 0.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MCKMcKesson CorporationFollow MCK — free
—
Price chart with a free account
- Market cap
- 116.7B
- P/E TTM
- 26.8
- Dividend yield
- 0.3%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
medical distribution · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| MCK | 117 | 26.8 | 0.3 | 16.7 | 5.3% | +9% | 2% | 287% |
| COR | 63 | 24.6 | 0.2 | 17.7 | 6.4% | +5% | 0.9% | 22% |
| CAH | 58 | 34.5 | 0.2 | 17.4 | 7.8% | +14% | 1% | 136% |
| HSIC | 9.5 | 24.8 | 0.9 | 12.7 | 5.4% | +6% | 5% | 8% |
| ACH | 0.0 | — | 0.7 | 6.1 | — | -3% | 1% | 2% |
| MEDS | 0.0 | — | 4.5 | — | — | -78% | — | -418% |
| Median of these 5 | 24.8 | 0.7 | 15.0 | 6.4% | +5% | 1% | 8% |
P/E 26.8 vs. a peer median of 24.8; EV/Sales 0.3 vs. 0.7. MCK's own P/E sits at the 58th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesACH and MEDS have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
McKesson Corporation — questions
- What is McKesson Corporation's market cap?
- $116.7B.
- What is McKesson Corporation's P/E ratio?
- 26.8 on trailing twelve-month earnings to 2026-06-30.
- What is McKesson Corporation's price-to-sales ratio?
- 0.3.
Every figure on this page comes from McKesson Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.